Pharma 16: Psychosis and Mania - Reality, Regulation, and Restraint

This episode examines the pharmacological treatment of psychosis and mania as an exercise in regulation rather than suppression. Antipsychotics and mood stabilisers act on systems that assign meaning, importance, and momentum to thoughts and experiences. We move beyond dopamine reduction as a slogan to understand why these drugs work, why they take time, and why adverse effects often mirror the systems being modulated. The emphasis is on proportionality—reducing pathological intensity while preserving function and dignity.Key takeaways you’ll build and reuse throughout the series:* Salience and signalling: how dysregulated dopamine transmission alters perception, belief, and behavioural drive.* Antipsychotics as modulators: typical and atypical agents reframed by receptor profiles and downstream effects.* Mania as acceleration: why mood stabilisation targets rhythm, impulse, and amplitude rather than mood alone.* Side-effects as system echoes: extrapyramidal symptoms, metabolic change, and sedation explained mechanistically.* Clinical judgement in context: matching agent, dose, and tempo to illness phase, vulnerability, and patient priorities. This is a public episode. If you'd like to discuss this with other subscribers or get access to bonus episodes, visit drmanaankarray.substack.com/subscribe